CSDX.US CS Diagnostics Corp.
- Market cap
- USD 17.4M
- P/E
- -
- P/B
- 0.03x
- ROE
- 0.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is CSDX.US undervalued?
Graham numberThe Graham number of CS Diagnostics Corp. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CS Diagnostics Corp. fundamental analysis
No fundamental analysis for CS Diagnostics Corp. yet.
CS Diagnostics Corp. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CS Diagnostics Corp.
CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant protection product; and CS-Protect Hydrogel, a proprietary oncology medical device used in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Cheyenne, …
Full company profileCS Diagnostics Corp. financial statements
CS Diagnostics Corp. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2024 | 2025 |
|---|---|---|
| Income Statement | ||
| Revenue | 0.00 | 0.00 |
| Operating Income | 761.00 | 71.2K |
| EBITDA | 761.00 | 71.2K |
| Net Income | 761.00 | 71.2K |
| EPS | 0.00 | 0.00 |
| Balance Sheet | ||
| Total Assets | 499M | 499M |
| Total Liabilities | 1.43K | 15.3K |
| Shareholders' Equity | 499M | 499M |
| Cash & Short-term Investments | 501.00 | 6.81K |
| Cash Flow | ||
| Operating Cash Flow | 11.0K | 6.31K |
| Capital Expenditure | 0.00 | 0.00 |
| Free Cash Flow | 11.0K | 6.31K |
| Ratios | ||
| ROE | 0.0% | 0.0% |
| ROA | 0.0% | 0.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
CS Diagnostics Corp. dividends
CS Diagnostics Corp. has not paid dividends in the last 2 fiscal years.
Last stock split: 200:100000 on Aug 3, 2023.
Who owns CS Diagnostics Corp.
- Insiders 85.45%
- Institutions 0.00%
- Public & others 14.55%
- Shares outstanding 250M
- Free float 46.1M
CS Diagnostics Corp. company profile
- Company name
- CS Diagnostics Corp.
- Ticker
- CSDX.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Medical Devices
- Fiscal year end
- December
- Address
- 1603 Capitol Avenue, Cheyenne, WY, United States, 82001
- Phone
- 307 395 7333
- Website
- csdcorp.us
About CS Diagnostics Corp.
CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant protection product; and CS-Protect Hydrogel, a proprietary oncology medical device used in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Cheyenne, Wyoming.
CS Diagnostics Corp. management
5- Mr. Thomas FahrhoeferPresident, Chairman & CEO · born 1970
- Mr. Mohammad EsSayedVP, CFO & Director · born 1978
- Mr. Thomas J. MigotschVP & COO · born 1977
- Ms. Sabrina Kummer GodehardtDirector of Business Development & Director · born 1980
- Ms. Janel LuzanaCorporate Secretary